Cargando…
Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease
The compounds 1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl nitrate (C1), (1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl nitrate (C2), 3-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzyl nitrate (C3), 4-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-N-hydroxy-benzenesulfonamide (C4), 4-(1,3-dioxo-1,3-dihydro-...
Autores principales: | dos Santos, Jean Leandro, Longhin Bosquesi, Priscila, Varanda, Eliana Aparecida, Moreira Lima, Lídia, Chung, Man Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260610/ https://www.ncbi.nlm.nih.gov/pubmed/21471937 http://dx.doi.org/10.3390/molecules16042982 |
Ejemplares similares
-
Mutagenicity of New Lead Compounds to Treat Sickle Cell Disease Symptoms in a Salmonella/Microsome Assay
por: dos Santos, Jean Leandro, et al.
Publicado: (2010) -
Mutagenic and Genotoxic Effect of Hydroxyurea
por: Santos, Jean L., et al.
Publicado: (2011) -
Anti-Inflammatory Drug Design Using a Molecular Hybridization Approach
por: Bosquesi, Priscila Longhin, et al.
Publicado: (2011) -
Advances in Drug Design Based on the Amino Acid Approach: Taurine Analogues for the Treatment of CNS Diseases
por: Chung, Man Chin, et al.
Publicado: (2012) -
Synthesis and Preliminary Evaluation of N-Oxide Derivatives for the Prevention of Atherothrombotic Events
por: Rosseto, Leandro Augusto, et al.
Publicado: (2015)